Source: https://patents.google.com/patent/US10029063B2/en
Timestamp: 2019-04-25 14:25:45
Document Index: 783782072

Matched Legal Cases: ['Application No. 2009202232', 'Application No. 200910163947', 'Application No. 2009', 'Application No. 07784697', 'Application No. 589634', 'Application No. 09', 'Application No. 589634', 'Application No. 2003275762', 'Application No. 2009', 'Application No. 200910163947', 'Application No. 200910163947', 'Application No. 03810331']

US10029063B2 - Patient interface systems - Google Patents
US10029063B2
US10029063B2 US14/534,251 US201414534251A US10029063B2 US 10029063 B2 US10029063 B2 US 10029063B2 US 201414534251 A US201414534251 A US 201414534251A US 10029063 B2 US10029063 B2 US 10029063B2
US14/534,251
US20150059760A1 (en
2009-07-15 Priority to US8084709P priority
2011-02-16 Priority to US201161457272P priority
2011-10-27 Priority to US201161552064P priority
2012-02-14 Priority to US13/372,792 priority patent/US8905031B2/en
2014-11-06 Priority to US14/534,251 priority patent/US10029063B2/en
2014-11-06 Assigned to RESMED LIMITED reassignment RESMED LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARLOW, ADAM FRANCIS
2014-11-06 Application filed by ResMed Ltd filed Critical ResMed Ltd
2015-03-05 Publication of US20150059760A1 publication Critical patent/US20150059760A1/en
2018-07-24 Publication of US10029063B2 publication Critical patent/US10029063B2/en
This application is a continuation of U.S. Ser. No. 13/372,792 filed Feb. 14, 2012, now allowed, which is a continuation-in-part of U.S. Ser. No. 12/478,537 filed Jun. 4, 2009, now U.S. Pat. No. 8,291,906, which claims the benefit of U.S. Provisional Application Nos. 61/058,659 filed Jun. 4, 2008 and 61/080,847 filed Jul. 15, 2008, and this application also claims benefit of U.S. Provisional Application Nos. 61/457,272, filed Feb. 16, 2011 and 61/552,064 filed Oct. 27, 2011, each of the above applications being incorporated by reference in its entirety.
1. A patient interface system configured to deliver pressurized breathable gas to a patient's airways, the patient interface system comprising:
a patient interface comprising a sealing portion configured to sealingly engage a patient's nose when the patient interface system is mounted on the patient's face; and
a suspension system with an adhesive layer configured to be adhered to the patient's face, the suspension system being connected to the patient interface and configured to suspend the patient interface on the patient's face without any hard parts in a manner that maintains a sealed air path between the patient interface and the patient's nose,
wherein the sealing portion of the patient interface extends through an aperture in the suspension system so that the suspension system supports the patient interface.
7. A patient interface system according to claim 1, wherein the adhesive layer is configured to be supported on the patient's nasal bridge, and wherein the patient interface is configured to only seal under the patient's nose and is suspended from the adhesive layer by the suspension system.
9. A patient interface system according to claim 1, wherein the patient interface and the adhesive layer are configured to engage different portions of the patient's face when the patient interface system is mounted on the patient's face.
10. A patient interface system according to claim 1, wherein a rim of the aperture supports the patient interface.
11. A patient interface system according to claim 1, wherein the patient interface and the suspension system are removably attached to each other.
12. A patient interface system configured to deliver pressurized breathable gas to a patient's airways, the patient interface system comprising:
a suspension system with an adhesive portion configured to be adhered to the patient's face, the suspension system being connected to patient interface and configured to suspend the patient interface on the patient's face in a manner that maintains a sealed air path between the patient interface and the patient's nose,
wherein the patient interface and the suspension system do not include any hard parts,
wherein hard parts are unbendable parts or are bendable parts that retain their bent shape at room temperature in the absence of force acting on the hard part, and
13. A patient interface system according to claim 12, wherein the patient interface system does not include polycarbonate material.
14. A patient interface system according to claim 12, wherein the suspension system comprises an adhesive pad adapted to be positioned on the patient's face and a primary headgear connecting the patient interface to the suspension system.
15. A patient interface system according to claim 14, wherein the primary headgear is configured to be supported on the patient's nasal bridge.
16. A patient interface system according to claim 15, wherein the primary headgear comprises the aperture through which said sealing portion of the patient interface extends.
17. A patient interface system according to claim 16, wherein the primary headgear wraps around the patient interface in a sling-like fashion.
18. A patient interface system according to claim 12, wherein the patient interface system does not include a hard shell or frame.
19. A patient interface system configured to deliver pressurized breathable gas to a patient's airways, the patient interface system comprising:
a suspension system with an adhesive portion configured to be adhered to the patient's face, the suspension system being connected to the patient interface and configured to suspend the patient interface on the patient's face in a manner that maintains a sealed air path between the patient interface and the patient's nose,
wherein the materials comprising the patient interface and the suspension system include only materials that are soft, compliant and flexible, and
20. A patient interface system according to claim 19, wherein the suspension system comprises an adhesive pad adapted to be positioned on the patient's face and a primary headgear connecting the patient interface to the suspension system.
21. A patient interface system according to claim 20, wherein the patient interface comprises elastomeric material.
22. A patient interface system according to claim 21, wherein the primary headgear comprises a flexible composite material.
23. A patient interface system according to claim 22, wherein the flexible composite material comprises at least one of laminated foam, nonwoven fabric and mesh.
24. A patient interface system according to claim 19, wherein the patient interface and the suspension system are configured to inter-engage and/or interlace with one another without requiring a hard frame or shell and without requiring one or more separate clips.
US14/534,251 2008-06-04 2014-11-06 Patient interface systems Active 2029-11-18 US10029063B2 (en)
US8084709P true 2009-07-15 2009-07-15
US201161457272P true 2011-02-16 2011-02-16
US201161552064P true 2011-10-27 2011-10-27
US13/372,792 US8905031B2 (en) 2008-06-04 2012-02-14 Patient interface systems
US14/534,251 US10029063B2 (en) 2008-06-04 2014-11-06 Patient interface systems
US16/015,388 US20180296786A1 (en) 2008-06-04 2018-06-22 Patient interface systems
US13/372,792 Continuation US8905031B2 (en) 2008-06-04 2012-02-14 Patient interface systems
US16/015,388 Continuation US20180296786A1 (en) 2008-06-04 2018-06-22 Patient interface systems
US20150059760A1 US20150059760A1 (en) 2015-03-05
US10029063B2 true US10029063B2 (en) 2018-07-24
US13/372,792 Active US8905031B2 (en) 2008-06-04 2012-02-14 Patient interface systems
US14/534,251 Active 2029-11-18 US10029063B2 (en) 2008-06-04 2014-11-06 Patient interface systems
US16/015,388 Pending US20180296786A1 (en) 2008-06-04 2018-06-22 Patient interface systems
US (3) US8905031B2 (en)
US9968753B2 (en) * 2014-06-13 2018-05-15 Linda Humphries Nasally mounted respiratory mask
EP3337547A1 (en) * 2015-08-21 2018-06-27 3M Innovative Properties Company Nasogastric tube securement systems and methods of using same
EP3337548A1 (en) * 2015-08-21 2018-06-27 3M Innovative Properties Company Nasogastric tube securement systems and methods of using same
CN107921238A (en) * 2015-08-21 2018-04-17 3M创新有限公司 Nasogastric tube securement systems and methods of using same
CN105363146A (en) * 2015-12-14 2016-03-02 海峡医疗器械工程研究中心（常州）有限公司 Suspension type wet purifying nasal mask for assisting purifying of micro-fine suspension particles
JP2005087766A (en) 1996-06-06 2005-04-07 Creative Integration & Design Inc Nasal dilator with area of adhesive engagement of varying strength
2012-02-14 US US13/372,792 patent/US8905031B2/en active Active
2014-11-06 US US14/534,251 patent/US10029063B2/en active Active
2018-06-22 US US16/015,388 patent/US20180296786A1/en active Pending
JP2009502429A (en) 2005-08-02 2009-01-29 アールアイシー・インベストメンツ・エルエルシー Mask mounting device
JP2009545408A (en) 2006-08-04 2009-12-24 アールアイシー インヴェストメンツ，エルエルシー Nose and mouth patient interface
Australia Patent Examination Report No. 1 for corresponding Australian Application No. 2009202232, dated Sep. 4, 2012, 4 pages.
Chinese Notification of First Office Action and English Translation for corresponding Chinese Application No. 200910163947.3, dated Dec. 13, 2012, 8 pages.
Decision of Rejection and English Translation for corresponding Japanese Application No. 2009-135413, dated Dec. 24, 2013, 6 pages.
European Search Report dated Jul. 27, 2009 in EP Application No. 07784697.0.
European Search Report issued in EP 07845378.4, dated Dec. 1, 2009.
Examination Report dated Dec. 8, 2010 in New Zealand Application No. 589634 (3 pages).
Examination Report dated Feb. 28, 2011 in European Application No. 09 161 984.1 (4 pages).
Examination Report for corresponding New Zealand Application No. 589634, dated Apr. 26, 2012, 2 pages.
Examiner's Report No. 3 dated Nov. 18, 2009 in New Zealand Application No. 2003275762.
International Search Report for PCT/AU2006/000770, dated Jun. 30, 2005.
Notice of Reasons for Rejection and English Translation issued in corresponding Japanese Application No. 2009-135413, dated Jul. 2, 2013, 7 pages.
Notification of the Fourth Office Action dated Oct. 10, 2014 in Chinese Application No. 200910163947.3, with English Translation (11pages).
Notification of the Third Office Action and English Translation for corresponding Chinese Application No. 200910163947.3, dated Mar. 13, 2014, 11 pages.
Office Action dated Dec. 22, 2009 in European Appln. No. 04802133.1.
ResMed Co.-Mask Products-http://resmed.com/portal/site/ResMedUS/index.jsp?. . . .
Snapp Nasal Interface, Tiara Medical Systems, Inc.-http://www.tiaramed.com/asp_shops/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface.
Supplementary European Search Report dated Dec. 18, 2009 in European Application No. 03810331.3.
Supplementary European Search Report dated Sep. 8, 2009 in European Appln. No. 04802133.1.
U.S. Appl. No. 10/584,711, filed Dec. 2004, Davidson
U.S. Appl. No. 61/071,514, filed May 2008, Guney et al.
US20150059760A1 (en) 2015-03-05
US20120138060A1 (en) 2012-06-07
US20180296786A1 (en) 2018-10-18
US8905031B2 (en) 2014-12-09
EP2591818A2 (en) 2013-05-15 Headgear assembly for a respiratory mask assembly
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BARLOW, ADAM FRANCIS;REEL/FRAME:034115/0954